HHLR ADVISORS, LTD.HHLR ADVISORS, LTD.

Institutional investor · Portfolio as of Q1 2026

Top Holdings38 positions

Checking export access…
Activity:
PDDPDD
ADR

PDD HOLDINGS INC

4.2M$425.6M25.4%$113.43-9.92%
16 qtrssince 2022-Q2
Decreased
0
BABABABA
ADR

ALIBABA GROUP HLDG LTD

2.5M$307.8M18.4%$144.74-14.11%
16 qtrssince 2022-Q2
Decreased
0
ONCONC
ADR

BEONE MEDICINES LTD

1M$307.2M18.4%$136.90+169.59%
30 qtrssince 2018-Q4
Unchanged
0
FUTUFUTU
ADR

Futu Holdings Ltd Spon ADS Cl

1.4M$194.1M11.6%$93.48+43.99%
8 qtrssince 2024-Q2
Decreased
0
LEGNLEGN
ADR

LEGEND BIOTECH CORP

6M$108.3M6.5%$50.33-64.51%
24 qtrssince 2020-Q2
Unchanged
0

ARRIVENT BIOPHARMA INC

3.9M$90.6M5.4%$17.95+33.40%
9 qtrssince 2024-Q1
Unchanged
0
BEKEBEKE
ADR

KE HLDGS INC

4.2M$63.4M3.8%$20.87-29.56%
23 qtrssince 2020-Q3
Unchanged
0
CWANCWANDelisted

CLEARWATER ANALYTICS HLDGS I

1.4M$32.3M1.9%$22.00+11.64%
4 qtrssince 2025-Q2
Unchanged
0

CYTEK BIOSCIENCES INC

6.7M$29.1M1.7%$21.41-79.59%
19 qtrssince 2021-Q3
Unchanged
0

MARVELL TECHNOLOGY INC

171,033$16.9M1.0%$98.980.00%
1 qtr
New
65
YSYSG
ADR

YATSEN HOLDING LTD

4.9M$15M0.9%$10.59-64.31%
22 qtrssince 2020-Q4
Unchanged
0
NBPNBP
ADR

I MAB

6M$14.7M0.9%$47.24-93.23%
23 qtrssince 2020-Q3
Unchanged
0

MAZE THERAPEUTICS INC

366,028$10.9M0.7%$11.42+286.87%
5 qtrssince 2025-Q1
Decreased
0

CONTINEUM THERAPEUTICS INC

669,337$8.7M0.5%$17.61-19.93%
8 qtrssince 2024-Q2
Unchanged
0
APIAPI
ADR

AGORA INC

2.1M$7.4M0.4%$4.20+8.57%
6 qtrssince 2024-Q4
Unchanged
0

WEBULL CORP

1.5M$7.2M0.4%$10.83-44.97%
4 qtrssince 2025-Q2
Decreased
0
TSMTSM
ADR

TAIWAN SEMICONDUCTOR MANUFAC

15,520$5.2M0.3%$310.97+8.13%
2 qtrssince 2025-Q4
Increased
43

SAGIMET BIOSCIENCES INC

724,800$3.8M0.2%$8.80-36.14%
11 qtrssince 2023-Q3
Unchanged
0
TUYATUYA
ADR

TUYA INC

1.6M$3.6M0.2%$19.42-88.11%
21 qtrssince 2021-Q1
Unchanged
0

GE AEROSPACE

10,043$2.8M0.2%$205.55+37.67%
9 qtrssince 2024-Q1
Unchanged
0
$1.7B
AUM
38
Positions
Q1 2026
Filing
HI score · 2.0/5
Quarterly 13F Value Change
-37%Q4'24$2.9B+23%Q1'25$3.5B-12%Q2'25$3.1B+32%Q3'25$4.1B-24%Q4'25$3.1B-46%Q1'26$1.7B
Activity profile
$ moved · Q1'26
New2%Increased0%Decreased98%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.0 years
<1Q16%1-4Q16%1-2Y8%2Y+61%

HHLR ADVISORS, LTD. manages $1.7B across 38 positions as of Q1 2026. Top holdings: PDD (25.4%), BABA (18.4%), ONC (18.4%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2/5.0.

Q1 2026 Summary

Active quarter - 9 new positions, 4 exits, 2 increased. Top move: MRVL (NEW, conviction 65). Portfolio: $1.7B across 38 positions.

Top holdings by portfolio weight

Total AUM$2B
PDD25.44%
BABA18.40%
ONC18.36%
FUTU11.60%
LEGN6.47%
AVBP5.42%
BEKE3.79%
CWAN1.93%
CTKB1.74%
MRVL1.01%
Other0.90%

Portfolio allocation by GICS sector

Sectors10
Consumer Cyclical44.08%
Healthcare34.48%
Financial Services11.60%
Technology4.71%
Real Estate3.79%
Consumer Defensive0.95%
Industrials0.17%
Basic Materials0.13%
Utilities0.04%
Unknown0.04%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Consumer Cyclical, Healthcare, Financial Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L23
Conviction41
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used